The 77 SNPs used to compute the PRS [6 ] were genotyped for the eight studies either as part of a GWAS (Illumina, Human Hap550) [34 (link)] or on a custom Illumina iSelect genotyping array comprising 211,155 SNPs (iCOGS, described in [1 (link)]). Quality control was conducted at the study level, as previously described [1 (link), 35 ]; call rates were > 95% for all SNPs. Thus, 77 SNPs associated with breast cancer and their published odds ratios were used to form the PRS.
Free full text: Click here